Toronto, Ontario–(Newsfile Corp. – March 24, 2022) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “ Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the preliminary data from the National Research Council of Canada (NRC), from studies on the neuroprotective…


Previous articleCybin Announces Additional Adelia Milestone Achievement
Next articleMydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study